Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
about
Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profileAdrenal crises: perspectives and research directions.A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Treatment and health outcomes in adults with congenital adrenal hyperplasia.Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiencyFertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia.Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Sexual well-being in adult male patients with congenital adrenal hyperplasia.Clinical outcomes in the management of congenital adrenal hyperplasia.Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.Biochemical and genetic diagnosis of 21-hydroxylase deficiency.Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia.Congenital Adrenal Hyperplasia.Assessment of early atherosclerosis and left ventricular dysfunction in children with 21-hydroxylase deficiency.Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia.Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review
P2860
Q28740875-02AC09FC-558F-4827-A1BE-3D1A8A9A1B3AQ30239976-8F504DF1-5F07-4A75-8506-86D9A5BC96ABQ33570221-E8E2C5F4-5A2F-4506-92A0-37B9D62605D9Q34377663-85DA3806-D3E4-4C8D-8B67-DB2D9C49BD4CQ34392232-FAD85108-76F3-438B-B6E3-E9FD9E6AADDCQ34427620-66E36622-5ACF-48FD-9E6F-9C867941165AQ35789682-B2C00F5A-15D5-42A3-9A38-D2A05381051BQ36436509-C38373F2-7055-4949-BCED-848844EAB6C1Q37615045-D5C7FE92-06A0-4F7E-B10F-43FFB5B68DF9Q37974156-B587214B-E1BC-4CE3-A71C-75DF2BC1F67FQ38071012-44C003EC-A57F-44E9-98B1-265C89A11C9CQ38529981-7E382670-D01C-44AC-A9F2-84C36D48D959Q38580103-7880AE61-53B5-410D-AC32-3B716D66F031Q38948900-AE538748-0F78-4FDB-ABA0-04C515D06D2AQ39032544-EEF9762C-B238-4CDC-A5CA-BDF36F32AADAQ44527005-E3E096C1-B02E-4310-ABC1-33848D47CB92Q51031432-91E94790-FC20-493D-A9CE-BBE10CD399A8Q51275699-373FE7C9-9FA4-4EF7-AF2B-685F57331454Q51317526-45B4A229-AAAB-49AB-8264-636EC960B5F2Q57137398-A2EB1862-30FA-4BC4-9443-4EA0E7A12F1F
P2860
Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@ast
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@en
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@nl
type
label
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@ast
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@en
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@nl
prefLabel
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@ast
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@en
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@nl
P356
P1476
Cardiovascular risk, metabolic ...... e to 21-hydroxylase deficiency
@en
P2093
Anna Wedell
Marja Thorén
P304
P356
10.1530/EJE-10-0877
P407
P577
2011-02-01T00:00:00Z